Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL

SummaryQuotesNewsCompany 
News SummaryMost relevantAll newsSector news 

Auxilium Pharmaceuticals, Inc. : RDInvesting Provides Investors with Free In-Depth Equity Reports on AUXL, ENV, GLUU and ZMH

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/24/2013 | 03:05pm CET

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) shares increased 4.45 percent to close at $17.12 a share Tuesday. The stock traded between $16.51 and $17.12 on volume of 832,089 shares traded. Analysts at JMP Securities have recently initiated coverage on the company with an "outperform" rating and a price target of $24.00. Shares of Auxilium Pharmaceuticals have fallen approximately 8.0 percent year-to-date.

Find out more about Auxilium Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/AUXL

Envestnet Inc. (NYSE: ENV) shares increased 1.60 percent to close at $36.92 a share Tuesday. The stock traded between $36.40 and $37.31 on volume of 248,852 shares traded. Analysts at Barrington have recently initiated coverage on the company with an "outperform" rating and a price target of $45.00. Shares of Envestnet have gained approximately 165.0 percent year-to-date.

Find out more about Envestnet including full access to the free equity report at:
www.RDInvesting.com/ENV

Glu Mobile Inc. (NASDAQ: GLUU) shares increased 0.59 percent to close at $3.25 a share Tuesday. The stock traded between $3.22 and $3.38 on volume of 4.16 million shares traded. Analysts at Cowen have recently initiated coverage on the company with an "outperform" rating and a price target of $5.00. Shares of Glu Mobile have gained approximately 42.0 percent year-to-date.

Find out more about Glu Mobile including full access to the free equity report at:
www.RDInvesting.com/GLUU

Zimmer Holdings, Inc. (NYSE: ZMH) shares gained 0.45 percent to close at $88.72 a share Tuesday. The stock traded between $87.81 and $89.31 on volume of 1.19 million shares traded. Analysts at Credit Suisse have recently upgraded the company?s rating to "outperform" from "neutral". Shares of Zimmer Holdings have gained approximately 33.0 percent year-to-date.

Find out more about Zimmer Holdings including full access to the free equity report at:
www.RDInvesting.com/ZMH

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AUXILIUM PHARMACEUTICALS,
2015 EXCLUSIVE : Drugmaker Endo vying for Salix takeover
2015 AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
2015DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
2014 AUXILIUM PHARMACEUTICALS : Sobi's Xiapex receives positive opinion by CHMP for t..
2014 AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
2014 AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
2014 AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
2014 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
2014 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
2014 AUXILIUM PHARMACEUTICALS : to Present XIAFLEX and STENDRA Data at SMSNA Scientif..
More news
Sector news : Biopharmaceuticals
12:36a Pharma execs weigh in on possible changes under Trump
12:24aDJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
12/01 GLAXOSMITHKLINE : GSK biotech asthma drug wins UK approval after extra price cut
More sector news : Biopharmaceuticals
News from SeekingAlpha
2015 Vivus' Stendra To Get A Re-Launch
2015 FDA imposes limits on testosterone drugs and labeling changes to warn of pote..
2015 WINNERS CIRCLE 2014 TOP HEDGE FUND M : Healthcare Funds, Nine Of Top Ten Spots
Advertisement
Managers
NameTitle
Rajiv De Silva President, Chief Executive Officer & Director
Suketu P. Upadhyay Chief Financial Officer, Director & Executive VP
Karen A. Wallace Treasurer & Senior Vice President
Caroline B. Manogue Secretary, Chief Legal Officer & Executive VP
Guy T. Donatiello Senior Vice President-Intellectual Property
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AUXILIUM PHARMACEUTICA..0.00%0
BIOGEN INC-3.45%64 354
CSL LIMITED-6.94%33 396
ALEXION PHARMACEUTICAL..-36.04%27 360
BIOMARIN PHARMACEUTICA..-18.26%14 332
GRIFOLS SA-15.08%12 353
More Results